Skip to main content
. 2017 Oct 31;89(5):482–487. doi: 10.1136/jnnp-2017-316864

Table 4.

Features supporting and contravening diagnosis of Perry syndrome

Clinical features Laboratory features
Supporting features Non-supporting features Supporting features Non-supporting features
(1) Frontal signs (1) Hypoxia and hypercapnia due to cardiac and pulmonary diseases (1) MRI/CT: normal or frontotemporal atrophy (1) Genetic test: mutation in the MAPT gene
(2) Oculomotor disorders (2) Seizures (2) Functional imaging: reduction of striatal tracer uptake (2) Pathology: evidence of other neurodegenerative diseases
(3) Cognitive impairment (3) Myoclonus (3) Cardiac MIBG scintigraphy: decreased uptake
(4) Autonomic dysfunction (4) Cerebellar ataxia (4) Functional imaging: frontotemporal hypometabolism
(5) Sleep disturbances (5) Sensory impairment
(6) Amyotrophy

MIBG, [123I]-metaiodobenzylguanidine.